Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
Тип публикации: Journal Article
Дата публикации: 2020-02-01
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR: 1.287
CiteScore: 11.4
Impact factor: 8.7
ISSN: 01418130, 18790003
PubMed ID:
31838071
Biochemistry
Molecular Biology
General Medicine
Structural Biology
Краткое описание
Phospholipase A2 (PLA2) is the main constituent of snake venom. PLA2 enzymes catalyze the Ca2+ dependent hydrolysis of 2-acyl ester bonds of 3-sn-phospholipids, releasing fatty acids and lysophospholipids. Inside the body of the victim, PLA2 from snake venom induces either direct or indirect pathophysiological effects, including anticoagulant, inflammatory, neurotoxic, cardiotoxic, edematogenic, and myotoxic activities. Therefore, there is a need to find the potential inhibitors against PLA2 responsible for snakebite. In this study, we employed in silico and in vitro methods to identify the potential inhibitor against PLA2. Virtual screening and molecular docking studies were performed to find potent inhibitor against PLA2 using Traditional Chinese Medicine Database (TCM). Based on these studies, Scutellarin (TCM3290) was selected and calculated by density functional theory calculation at B3LYP/6-31G**++ level to explore the stereo-electronic features of the molecule. Further, molecular docking and DFT of Minocycline was carried out. Quantum polarized ligand docking was performed to optimize the geometry of the protein-ligand complexes. The protein-ligand complexes were subjected to molecular dynamics simulation and binding free energy calculations. The residence time of a protein-ligand complex is a critical parameter affecting natural influences in vitro. It is nonetheless a challenging errand to expect, regardless of the accessibility of incredible PC assets and a large variety of computing procedures. In this metadynamics situation, we used the conformational flooding technique to deal with rank inhibitors constructions. The systematic free energy perturbation (FEP) protocol and calculate the energy of both complexes. Finally, the selected compound of TCM3290 was studied in vitro analysis such as inhibition of PLA2 activity, hyaluronidase activity and fibrinogenolytic activity. The TCM3290 had a more binding affinity compare to Minocycline, and interacted with the key residues of TYR63 and GLY31. DFT represented the highest HOMO and LUMO energy of 0.15146 eV. MD simulation with 100 ns proved that an inhibitor binding mode is more stable inside the binding site of PLA2. In vitro analysis shows that TCM3290 significantly neutralized by PLA2. The above observations confirmed that Scutellarin (TCM3290) had a potent snake venom neutralizing capacity and could hypothetically be used for therapeutic drives of snakebite envenomation.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
3
4
|
|
|
Journal of Biomolecular Structure and Dynamics
4 публикации, 10.53%
|
|
|
Frontiers in Chemistry
2 публикации, 5.26%
|
|
|
Journal of Physical Chemistry B
2 публикации, 5.26%
|
|
|
International Journal of Molecular Sciences
1 публикация, 2.63%
|
|
|
Frontiers in Bioengineering and Biotechnology
1 публикация, 2.63%
|
|
|
Vaccines
1 публикация, 2.63%
|
|
|
Molecular Diversity
1 публикация, 2.63%
|
|
|
Applied Biochemistry and Biotechnology
1 публикация, 2.63%
|
|
|
Journal of Umm Al-Qura University for Applied Sciences
1 публикация, 2.63%
|
|
|
Structural Chemistry
1 публикация, 2.63%
|
|
|
Phytomedicine
1 публикация, 2.63%
|
|
|
Russian Chemical Reviews
1 публикация, 2.63%
|
|
|
PLoS ONE
1 публикация, 2.63%
|
|
|
Saudi Journal of Biological Sciences
1 публикация, 2.63%
|
|
|
Journal of King Saud University - Science
1 публикация, 2.63%
|
|
|
Animal Models and Experimental Medicine
1 публикация, 2.63%
|
|
|
ACS Omega
1 публикация, 2.63%
|
|
|
Journal of Receptor and Signal Transduction Research
1 публикация, 2.63%
|
|
|
IEEE/ACM Transactions on Computational Biology and Bioinformatics
1 публикация, 2.63%
|
|
|
Precision Clinical Medicine
1 публикация, 2.63%
|
|
|
Toxicon
1 публикация, 2.63%
|
|
|
Science of the Total Environment
1 публикация, 2.63%
|
|
|
Chemical Physics Impact
1 публикация, 2.63%
|
|
|
Frontiers in Pharmacology
1 публикация, 2.63%
|
|
|
Environmental Research
1 публикация, 2.63%
|
|
|
Scientific Reports
1 публикация, 2.63%
|
|
|
International Journal of Surgery
1 публикация, 2.63%
|
|
|
Molecular Biology Reports
1 публикация, 2.63%
|
|
|
International Journal of Biological Macromolecules
1 публикация, 2.63%
|
|
|
1
2
3
4
|
Издатели
|
1
2
3
4
5
6
7
|
|
|
Springer Nature
7 публикаций, 18.42%
|
|
|
Elsevier
7 публикаций, 18.42%
|
|
|
Taylor & Francis
6 публикаций, 15.79%
|
|
|
Frontiers Media S.A.
4 публикации, 10.53%
|
|
|
American Chemical Society (ACS)
3 публикации, 7.89%
|
|
|
MDPI
2 публикации, 5.26%
|
|
|
King Saud University
2 публикации, 5.26%
|
|
|
Wiley
2 публикации, 5.26%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 2.63%
|
|
|
Public Library of Science (PLoS)
1 публикация, 2.63%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 публикация, 2.63%
|
|
|
Oxford University Press
1 публикация, 2.63%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 публикация, 2.63%
|
|
|
1
2
3
4
5
6
7
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
38
Всего цитирований:
38
Цитирований c 2025:
3
(7.89%)
Цитировать
ГОСТ |
RIS |
BibTex
Цитировать
ГОСТ
Скопировать
Chinnasamy S. et al. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2) // International Journal of Biological Macromolecules. 2020. Vol. 144. pp. 53-66.
ГОСТ со всеми авторами (до 50)
Скопировать
Chinnasamy S., Selvaraj C., Kaushik A. C., Khan A., Singh S., Wei D. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2) // International Journal of Biological Macromolecules. 2020. Vol. 144. pp. 53-66.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1016/j.ijbiomac.2019.12.091
UR - https://doi.org/10.1016/j.ijbiomac.2019.12.091
TI - Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)
T2 - International Journal of Biological Macromolecules
AU - Chinnasamy, Sathishkumar
AU - Selvaraj, Chandrabose
AU - Kaushik, Aman Chandra
AU - Khan, Abbas
AU - Singh, Sanjeev
AU - Wei, Dong-Qing
PY - 2020
DA - 2020/02/01
PB - Elsevier
SP - 53-66
VL - 144
PMID - 31838071
SN - 0141-8130
SN - 1879-0003
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2020_Chinnasamy,
author = {Sathishkumar Chinnasamy and Chandrabose Selvaraj and Aman Chandra Kaushik and Abbas Khan and Sanjeev Singh and Dong-Qing Wei},
title = {Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2)},
journal = {International Journal of Biological Macromolecules},
year = {2020},
volume = {144},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016/j.ijbiomac.2019.12.091},
pages = {53--66},
doi = {10.1016/j.ijbiomac.2019.12.091}
}
Ошибка в публикации?